Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A patient-derived CTC culture assay for anticancer drug evaluation to guide therapy for personalized treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Assay validation with controls. (A) Screening of doxorubicin in microwell assay using MCF-7 cancer cell line. Cultures were imaged in situ after staining with LIVE (calcein-AM; green) and DEAD [ethidium bromide (EtBr); red] under 72 hours of exposure to doxorubicin. Clusters under high drug concentrations are mostly nonviable (red), whereas clusters under low drug concentrations are mostly viable (green). (B) Dose-response curve and corresponding IC50 value (0.78 ± 0.02 μM) of MCF-7 generated from viability results. Representative image shows an MCF-7 cell cluster within a microwell (inset). Scale bars, 50 mm. (C) Scatterplot demonstrating overall high gray values that reflect the absence of clusters from cultures of blood from healthy volunteers. Representative image shows cell debris generated within a microwell from culture of a healthy sample (inset). Scale bars, 50 mm.](https://figures.cochat.ai/paper-figures/7e88543c7fea46f48aab4f2c301110a5/liquid-biopsy-and-therapeutic-response-circulating-tumor-cell-cultures-for-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“composite collagen‐alginate microcapsules laden with breast cancer cells (MCF‐7) were reported to create 3D vascularized tumor spheroids by suspending these core–shell microbeads inside an external stromal cell‐laden collagen matrix”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fortunately, with the development of biofabrication techniques, microfluidic and 3D bioprinting technologies have been employed to create more in vivo‐like perfusable 3D tumor models in the biomimetic matrix.[ 72 , 161 ]”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Such heterogeneity is observed in the cohort of circulating tumor cells (CTCs) [12,13], which can be isolated from the peripheral bloodstream or cultured for further analyses.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“However, the markers used for CTC detection are not applicable to all its subpopulations (32), partly due to the process of epithelial-tomesenchymal transition (36).”
BackgroundSelf-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 2×
“This is a similar observation that has been suggested in previous reports for tumor-associatedmacrophages (22).”
ResultCirculating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Continuous inertial focusing, ordering, and separation of particles in microchannels
Di Carlo, D., Irimia, D., Tompkins, R. G., & Toner, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704958104 · Cited by 1,708
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656 · cited 1×
“Current imaging techniques for cancer evaluation [for example, computed tomography (CT) scan] also suffer from technical limitations (3, 4), which lead to false-negative findings.”
Method
Research works printed but not linked: 2
- 10.1111/j.1572-0241.2000.02091.x · doi:10.1111/j.1572-0241.2000.02091.x · Paper page
- I. J. Fidler, Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2’-deoxyuridine. J. Natl. Cancer Inst. 45, 773–782 (1970).
Cited by
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Biology, vulnerabilities and clinical applications of circulating tumour cells
Ring, A., Nguyen-Sträuli, B. D., Wicki, A., & Aceto, N. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00536-4 · Cited by 327
Circulating tumor cell isolation for cancer diagnosis and prognosis
Deng, Z., Wu, S., Wang, Y., & Shi, D. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104237 · Cited by 284
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Self-citationMechanobiology of Tumor Growth
Chaudhuri, P. K., Low, B. C., & Lim, C. T. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00042 · Cited by 192
Self-citationCirculating tumor cells: from new biological insights to clinical practice
Gu, X., Wei, S., & Lv, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01938-6 · Cited by 182
“175,505,506 Despite these advancements, signi fi cant enhancements to such work fl ows are necessary for their transition to clinical application.”
BackgroundTrujillo-de Santiago, G., Flores-Garza, B. G., Tavares-Negrete, J. A., Lara-Mayorga, I. M., González-Gamboa, I., Zhang, Y. S., Rojas-Martínez, A., Ortiz-López, R., & Álvarez, M. M. (2019) · Materials · doi:10.3390/ma12182945 · Cited by 184
Khoo, B. L., Grenci, G., Lim, Y. B., Lee, S. C., Han, J., & Lim, C. T. (2018) · Nature Protocols · doi:10.1038/nprot.2017.125 · Cited by 172
Self-citationJackson, J. M., Witek, M. A., Kamande, J. W., & Soper, S. A. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00016b · Cited by 172
Bone Metastasis of Breast Cancer
Tahara, R. K., Brewer, T. M., Theriault, R. L., & Ueno, N. T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_7 · Cited by 169
Yue, C., Jiang, Y., Li, P., Wang, Y., Xue, J., Li, N., Li, D., Wang, R., Dang, Y., Hu, Z., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1438111 · Cited by 158
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Duo, Y., Han, L., Yang, Y., Wang, Z., Wang, L., Chen, J., Xiang, Z., Yoon, J., Luo, G., & Tang, B. Z. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00244 · Cited by 125
EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
Genna, A., Vanwynsberghe, A. M., Villard, A. V., Pottier, C., Ancel, J., Polette, M., & Gilles, C. (2020) · Cancers · doi:10.3390/cancers12061632 · Cited by 124
“Thus, CTC cell lines [315,336–338] and 3D CTC-derived spheroid and organoids models [317,322–325 , 339] have”
BackgroundEpithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases
Francart, M., Lambert, J., Vanwynsberghe, A. M., Thompson, E. W., Bourcy, M., Polette, M., & Gilles, C. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24506 · Cited by 125
“Thus, several in vitro cultures and assays have been developed to examine viability, proliferative, or invasive properties of CTCs isolated from cancer patients (Gao et al., 2014; Martin et al., 2014; Khoo et al., 2015, 2016; AlixPanabieres et al., 2016).”
Li, W., Zhou, Z., Zhou, X., Khoo, B. L., Gunawan, R., Chin, Y. R., Zhang, L., Yi, C., Guan, X., & Yang, M. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202609 · Cited by 119
Self-citationThe Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
Kapeleris, J., Kulasinghe, A., Warkiani, M. E., Vela, I., Kenny, L., O'Byrne, K. J., & Punyadeera, C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00311 · Cited by 120
Selective particle and cell capture in a continuous flow using micro-vortex acoustic streaming
Collins, D. J., Khoo, B. L., Ma, Z., Winkler, A., Weser, R., Schmidt, H., Han, J., & Ai, Y. (2017) · Lab on a Chip · doi:10.1039/c7lc00215g · Cited by 105
Self-citationPei, H., Li, L., Han, Z., Wang, Y., & Tang, B. (2020) · Lab on a Chip · doi:10.1039/d0lc00577k · Cited by 107
Microfluidic cell isolation technology for drug testing of single tumor cells and their clusters
Bithi, S. S., & Vanapalli, S. A. (2017) · Scientific Reports · doi:10.1038/srep41707 · Cited by 96
Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
Kulasinghe, A., Tran, T., Blick, T., O'Byrne, K. J., Thompson, E. W., Warkiani, M. E., Nelson, C. C., Kenny, L., & Punyadeera, C. (2017) · Scientific Reports · doi:10.1038/srep42517 · Cited by 88
Capture of Circulating Tumour Cell Clusters Using Straight Microfluidic Chips
Kulasinghe, A., Zhou, J., Kenny, L., Papautsky, I., & Punyadeera, C. (2019) · Cancers · doi:10.3390/cancers11010089 · Cited by 87
“In addition, advances in microfluidic chip technologies have enabled functional analysis such as CTC expansion in vitro [19,20].”
BackgroundCirculating tumor microemboli: Progress in molecular understanding and enrichment technologies
Umer, M., Vaidyanathan, R., Nguyen, N., & Shiddiky, M. J. A. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.05.002 · Cited by 83
Eslami‐S, Z., Cortés‐Hernández, L. E., Thomas, F., Pantel, K., & Alix‐Panabières, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01819-1 · Cited by 87
Breast tumor-on-chip models: From disease modeling to personalized drug screening
Bano, S., Dahiya, U. R., Mishra, S., Ayache, J., Casquillas, G. V., Caballero, D., Reis, R. L., & Kundu, S. C. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.057 · Cited by 83
Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
Tellez-Gabriel, M., Cochonneau, D., Cadé, M., Jubelin, C., Heymann, M., & Heymann, D. (2018) · Cancers · doi:10.3390/cancers11010019 · Cited by 71
“The most cutting-edge development for efficient expansion of patient CTCs in vitro is based on a microfluidic system, where autologous immune cells and cancer cells are co-cultured making the establishment rapid and efficient [111].”
BackgroundCirculating tumor cell profiling for precision oncology
Labib, M., & Kelley, S. O. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12901 · Cited by 73
Novel approaches in cancer management with circulating tumor cell clusters
Rostami, P., Kashaninejad, N., Moshksayan, K., Saidi, M. S., Firoozabadi, B., & Nguyen, N. (2019) · Journal of Science Advanced Materials and Devices · doi:10.1016/j.jsamd.2019.01.006 · Cited by 77
Balakrishnan, A., Koppaka, D., Anand, A., Deb, B., Grenci, G., Viasnoff, V., Thompson, E. W., Gowda, H., Bhat, R., Rangarajan, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44404-y · Cited by 63
Self-citationLiquid biopsy in pancreatic cancer: the beginning of a new era
Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 68
Mao, S., Zhang, Q., Li, H., Zhang, W., Huang, Q., Khan, M., & Lin, J. (2018) · Chemical Science · doi:10.1039/c8sc03027h · Cited by 54
Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research
Kyriakopoulou, K., Koutsakis, C., Piperigkou, Z., & Karamanos, N. K. (2023) · FEBS Journal · doi:10.1111/febs.16778 · Cited by 56
“Microfluidics have been proven especially helpful for the study of cancer metastasis and angiogenesis and can also potentially harbour circulating tumour cells culture and drug screening [52].”
BackgroundYu, X., Wu, N., Chen, F., Wei, J., & Zhao, Y. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.03.027 · Cited by 52
Popova, A. A., & Levkin, P. A. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900100 · Cited by 51
Tan, Z.-L., Yue, C., Ji, S., Zhao, C., Jia, R., Zhang, Y., Liu, R., Li, D., Yu, Q., Li, P., et al. (2021) · The Oncologist · doi:10.1002/onco.13981 · Cited by 50
Macaraniag, C., Luan, Q., Zhou, J., & Papautsky, I. (2022) · APL Bioengineering · doi:10.1063/5.0093806 · Cited by 49
S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
Cayrefourcq, L., de Roeck, A., Garcia, C. H., Stoebner, P., Fichel, F., Garima, F., Perriard, F., Daurès, J., Meunier, L., & Alix‐Panabières, C. (2019) · Cells · doi:10.3390/cells8070755 · Cited by 50
Lee, H., Chiou, J.-F., Wang, P., Lu, L., Shen, C., Hsu, H.-L., Burnouf, T. P. R., Ting, L., Chou, P.-C., Chung, C., et al. (2020) · Cancers · doi:10.3390/cancers12113394 · Cited by 45
Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
Kapeleris, J., Kulasinghe, A., Warkiani, M. E., O’Leary, C. G., Vela, I., Leo, P., Sternes, P. R., O'Byrne, K. J., & Punyadeera, C. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-521 · Cited by 43
“The immortalization of stable long term cell lines hold vital clues when developing personalized treatments for cancer as well as testing of therapeutic effectiveness using drug screening (29).”
BackgroundCancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
Microfluidics for personalized drug screening of cancer
Menon, N. V., Lim, S. B., & Lim, C. T. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.008 · Cited by 44
Self-citationZhang, X., Ju, S., Wang, X., & Cong, H. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-019-00563-w · Cited by 38
Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature
Sayed, Z. S., Khattap, M. G., Madkour, M. A., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Abdelkawy, D. A., Wadan, A. S., Omar, I., & Nafady, M. H. (2024) · Discover Oncology · doi:10.1007/s12672-024-00949-7 · Cited by 44
Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis
Tadimety, A., Syed, A., Nie, Y., Long, C. R., Kready, K. M., & Zhang, J. X. J. (2016) · Integrative Biology · doi:10.1039/c6ib00202a · Cited by 36
Zhao, M., Mi, D., Ferdows, B. E., Li, Y., Wang, R., Li, J., Patel, D. N., Kong, N., Shi, S., & Tao, W. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101361 · Cited by 37
Khoo, B. L., Grenci, G., Lim, J. S. Y., Lim, Y. P., Fong, J., Yeap, W. H., Lim, S. B., Chua, S. L., Wong, S. C., Yap, Y. S., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0301-9 · Cited by 40
Self-citationXin, Y., Hu, B., Li, K., Hu, G., Zhang, C., Chen, X., Tang, K., Du, P., & Tan, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216870 · Cited by 37
An Inflection Point in Cancer Protein Biomarkers: What was and What's Next
Barker, A. D., Alba, M. M., Mallick, P., Agus, D. B., & Lee, J. S. H. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100569 · Cited by 36
“Liquid biopsy in general, and MCEDs, in particular, offer hope that achieving scale and application of stringent quality control metrics in sampling will significantly improve biomarkers for all phases of the patient’s journey—well beyond detecting early cancer “signals” (21, 22).”
BackgroundRole of liquid biopsies in colorectal cancer
Wills, B., Gorse, E., & Lee, V. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.08.004 · Cited by 39
Shang, M., Lim, S. B., Jiang, K., Yap, Y. S., Khoo, B. L., Han, J., & Lim, C. T. (2021) · Lab on a Chip · doi:10.1039/d0lc01103g · Cited by 36
Self-citationSun, Y., Wang, R., Qiao, M., Yan-chun, X., Guan, W., & Wang, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26433 · Cited by 38
“…cells), rare tumor cells shed from primary and metastatic tumors deposits into the peripheral circulation, is proposed to be an attractive source of liquid biopsy relevant to therapy response in GI and non-GI lately (Ao et al., 2015; Bredemeier et al., 2017; Khoo et al., 2016; Okubo et al., 2017).”
BackgroundZhang, T., Deng, Y., Yang, S. L., Chua, S. L., Tang, B. Z., & Khoo, B. L. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137579 · Cited by 31
Self-citationPrecision oncology using ex vivo technology: a step towards individualised cancer care?
Williams, S. T., Wells, G., Conroy, S., Gagg, H., Allen, R. J., Rominiyi, O., Helleday, T., Hullock, K., Pennington, C. E. W., Rantala, J., et al. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.32 · Cited by 37
Establishment and Characterization of a CTC Cell Line from Peripheral Blood of Breast Cancer Patient
Zhao, P., Zhou, W., Liu, C. X., Zhang, H., Cheng, Z., Wu, W., Liu, K., Hu, H., Zhong, C., Zhang, Y., et al. (2019) · Journal of Cancer · doi:10.7150/jca.33157 · Cited by 32
“Several breast cancer CTC cell lines have been generated from cancer patients and used to monitor response to anti-cancer drugs [15].”
BackgroundCell Lines of Circulating Tumor Cells: What Is Known and What Needs to Be Resolved
Shimada, Y., Sudo, T., Akamatsu, S., Sunada, T., Myomoto, A., Okano, K., & Shimizu, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050666 · Cited by 30
“Furthermore, the translational relevance of cell lines is often questioned because prolonged cultures and multiple passages lead to phenotypes that are no longer representative of the original tumor in terms of cell epigenetics and gene expression profiles [1].”
BackgroundSłomka, A., Wang, B., Mocan, T., Horhat, A., Willms, A. G., Schmidt‐Wolf, I. G. H., Strassburg, C. P., Gonzalez-Carmona, M. A., Kornek, M., & Kornek, M. (2022) · Theranostics · doi:10.7150/thno.73400 · Cited by 36
“for individualized drug susceptibility test) will be only achieved with CTCs [114, 124-126].”
BackgroundEslami‐S, Z., Cortés‐Hernández, L. E., Glogovitis, I., Antunes‐Ferreira, M., D’Ambrosi, S., Kurma, K., Garima, F., Cayrefourcq, L., Best, M. G., Koppers‐Lalic, D., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1209846 · Cited by 32
“Furthermore, establishing in vitro and in vivo CTC models is challenging and only few groups accomplished this challenge (Gao et al., 2014; Yu et al., 2014; Cayrefourcq et al., 2015; Khoo et al., 2016).”
BackgroundMentis, A. A., Grivas, P. D., Dardiotis, E., Romas, N. A., & Papavassiliou, A. G. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03529-4 · Cited by 34
Significance of circulating tumor cells in lung cancer: a narrative review
Hamilton, G., Rath, B., & Stickler, S. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-712 · Cited by 34
Pancreatic cancer circulating tumor cells: applications for personalized oncology
DiPardo, B. J., Winograd, P., Court, C. M., & Tomlinson, J. S. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1511429 · Cited by 28
Efficient Propagation of Circulating Tumor Cells: A First Step for Probing Tumor Metastasis
Xiao, J., McGill, J. R., Stanton, K., Kassner, J. D., Choudhury, S., Schlegel, R., Sauna, Z. E., Pohlmann, P. R., & Agarwal, S. (2020) · Cancers · doi:10.3390/cancers12102784 · Cited by 28
Anti-Cancer Drug Screening with Microfluidic Technology
Monjezi, M., Rismanian, M., Jamaati, H., & Kashaninejad, N. (2021) · Applied Sciences · doi:10.3390/app11209418 · Cited by 30
“The addition of inlets in the tree-like gradient generator facilitated the efficient screening of drugs as a combinatorial treatment [51].”
BackgroundZhang, Y., Yu, Y., Kang, K., Wang, X., Zhu, N., Wang, X., Yi, Q., & Wu, Y. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101817 · Cited by 27
Prospects for Comprehensive Analyses of Circulating Tumor Cells in Tumor Biology
Aoki, M., Shoji, H., Kashiro, A., Takeuchi, K., Shimizu, Y., & Honda, K. (2020) · Cancers · doi:10.3390/cancers12051135 · Cited by 26
“The development of CTC culturing techniques may also facilitate new drug screening methods, and there are also approaches for evaluating patient drug responses using an integrated microfluidic system involving microfabricated microwells [81].”
MethodAn on-chip cell culturing and combinatorial drug screening system
Sun, J., Liu, W., Li, Y., Gholamipour‐Shirazi, A., Abdulla, A., & Ding, X. (2017) · Microfluidics and Nanofluidics · doi:10.1007/s10404-017-1959-7 · Cited by 28
An update: circulating tumor cells in head and neck cancer
Kulasinghe, A., Hughes, B. G. M., Kenny, L., & Punyadeera, C. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1688145 · Cited by 29
“Conversely, a number of groups have shown that CTCs, including CTC clusters can be expanded in the short-term where drug sensitivity testing may be possible [50,54].”
BackgroundMa, Y., Deng, Y., Hua, H., Khoo, B. L., & Chua, S. L. (2023) · The ISME Journal · doi:10.1038/s41396-023-01446-5 · Cited by 26
Self-citationClinical applications of circulating tumor cells in metastasis and therapy
Yang, C., Liu, C., Xia, C., & Fu, L. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01733-y · Cited by 32
“A total of 24 breast cancer samples were used for this drug evaluation, and the potential for cluster formation was found to correlate inversely with increased drug concentration [192].”
Hydrophoresis — A Microfluidic Principle for Directed Particle Migration in Flow
Choi, S. (2020) · BioChip Journal · doi:10.1007/s13206-020-4107-5 · Cited by 23
Liquid Biopsy, the hype vs. hope in molecular and clinical oncology
Mohanty, A., Mohanty, S. K., Rout, S., & Pani, C. (2021) · Seminars in Oncology · doi:10.1053/j.seminoncol.2021.06.002 · Cited by 22
Neoh, K. H., Cheng, K. S., Wu, H., Chen, A., Sun, Y., Li, B., Cao, A., & Han, R. P. S. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c00912 · Cited by 21
Crook, T., Gaya, A. M., Page, R. L., Limaye, S. A., Ranade, A. A., Bhatt, A., Patil, S., Kumar, P., Patil, D., & Akolkar, D. B. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04189-8 · Cited by 22
Deng, Y., Fu, Y., Chua, S. L., & Khoo, B. L. (2023) · Small · doi:10.1002/smll.202205904 · Cited by 21
Self-citationPhenotype-related drug sensitivity analysis of single CTCs for medicine evaluation
Pei, H., Yu, M., Dong, D., Wang, Y., Li, Q., Li, L., & Tang, B. (2020) · Chemical Science · doi:10.1039/c9sc05566e · Cited by 20
Zhao, X., Ma, Y., Dong, X. R., Zhang, Z., Tian, X., Zhao, X., & Yang, Y. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-383 · Cited by 20
“Since peripheral blood samples could be conveniently and frequently collected, the identification of CTCs during treatment process may provide additional information on the responses to current chemotherapy (17,18,26,27).”
BackgroundLiquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications
Chudasama, D. Y., Katopodis, P., Stone, N., Haskell, J. A., Sheridan, H., Gardner, B., Urnovitz, H. B., Schütz, E., Beck, J., Hall, M., et al. (2019) · Cancers · doi:10.3390/cancers11030331 · Cited by 19
“Several possible advantages have been recently discussed, including the use of different biofluids (blood, urine, sputum, saliva), early warning of pending resistance, serial monitoring of patients undergoing numerous cycles of treatment, less risk to patients, especially those who are not candidates for invasive biop…”
BackgroundMolecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer
Boral, D., Liu, H. N., Kenney, S. R., & Marchetti, D. (2020) · Cancers · doi:10.3390/cancers12061626 · Cited by 20
Preclinical models to study patient-derived circulating tumor cells and metastasis
Suvilesh, K. N., Manjunath, Y., Pantel, K., & Kaifi, J. T. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.01.004 · Cited by 19
Circulating tumour cell PD-L1 test for head and neck cancers
Kulasinghe, A., Kenny, L., & Punyadeera, C. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.10.011 · Cited by 18
Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells
Gao, T., Li, W., Ma, J., Chen, Y., Wang, Z., Sun, N., & Pei, R. (2023) · Talanta · doi:10.1016/j.talanta.2023.124728 · Cited by 19
A melt-electrowritten filter for capture and culture of circulating colon cancer cells
Jørgensen, M. L., Müller, C., Sikkersoq, M., Nadzieja, M., Zhang, Z., Su, Y., Just, J., Spindler, K.-L. G., & Chen, M. (2020) · Materials Today Bio · doi:10.1016/j.mtbio.2020.100052 · Cited by 20
The next step: mechanisms driving adrenocortical carcinoma metastasis
Lalli, E., & Luconi, M. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0440 · Cited by 19
Loh, A. H. P., Angelina, C., Wong, M. K., Tan, S. H., Sukhatme, S. A., Yeo, T., Lim, S. B., Lee, Y. T., Soh, S. Y., Leung, W. H., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.939460 · Cited by 16
Self-citationKo, J. M. Y., Lam, K. O., Kwong, D. L. �., Wong, Y., Chan, F. S., Wong, C. L.-Y., Chan, K. K., Law, T. T., Chiu, K. W.-H., Lam, C. C. S., et al. (2023) · Cancers · doi:10.3390/cancers15030832 · Cited by 16
Integrating Microfabrication into Biological Investigations: the Benefits of Interdisciplinarity
Grenci, G., Bertocchi, C., & Ravasio, A. (2019) · Micromachines · doi:10.3390/mi10040252 · Cited by 17
Self-citationPark, J., Park, C., Sugitani, Y., Fujii, T., & Kim, S. H. (2022) · Lab on a Chip · doi:10.1039/d2lc00171c · Cited by 15
Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review
Aktar, S., Baghaie, H., Islam, F., Gopalan, V., & Lam, A. K.-Y. (2023) · Otolaryngology · doi:10.1002/ohn.186 · Cited by 14
Sobhanan, J., Takano, Y., Sugino, S., Hirata, E., Yamamura, S., & Biju, V. (2022) · NPG Asia Materials · doi:10.1038/s41427-021-00353-5 · Cited by 14
Pearl, M. L., Dong, H., Zhao, Q., Tulley, S., Dombroff, M., & Chen, W. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.08.018 · Cited by 11
Alves, J. M., Estévez‐Gómez, N., Valecha, M. V., Prado‐Lòpez, S., Tomás, L., Alvariño, P., Piñeiro, R., Muinelo‐Romay, L., Mondelo‐Macía, P., Salgado, M., et al. (2022) · Genomics · doi:10.1016/j.ygeno.2022.110500 · Cited by 11
Kujur, P. K., Flores, B. C. T., Ramalingam, N., Chinen, L. T. D., & Jeffrey, S. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35805-1_5 · Cited by 12
Xulu, K. R., Nweke, E. E., & Augustine, T. N. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1087432 · Cited by 12
“This approach, which involved the integration of microfluidics and tapered microwells were integrated with microfluidics, could be used to determine patient prognosis via the evaluation of the formation of CTC clusters (Khoo et al., 2016).”
MethodHua, H., Zhou, Y., Li, W., Zhang, J., Deng, Y., & Khoo, B. L. (2024) · Biomicrofluidics · doi:10.1063/5.0172146 · Cited by 12
Self-citationNanoemulsions to support ex vivo cell culture of breast cancer circulating tumor cells
Carmona-Ule, N., Abuín, C., Costa, C., Piñeiro, R., Pereira‐Veiga, T., Martínez-Peña, I., Hurtado, P., López‐López, R., de la Fuente, M., & Dávila-Ibáñez, A. B. (2020) · Materials Today Chemistry · doi:10.1016/j.mtchem.2020.100265 · Cited by 12
Wu, S., Wang, Y., & Shi, D. (2019) · Nano LIFE · doi:10.1142/s1793984419710016 · Cited by 10
Dong, H., Tulley, S., Zhao, Q., Cho, L., Chen, D., Pearl, M. L., & Chen, W. (2019) · Cancer Medicine · doi:10.1002/cam4.2218 · Cited by 10
Xu, Y., Hu, X., Yuan, Y., Liu, W., Wang, J., Yang, C., Shi, X., Qin, W., Wen, L., Lin, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202508878 · Cited by 13
Tian, W., Xie, Y., Su, H., Zheng, C., & Li, M. (2026) · Nano Letters · doi:10.1021/acs.nanolett.5c06160 · Cited by 10
Nishida, K., Sekida, S., Anada, T., & Tanaka, M. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01469 · Cited by 9
Arora, S., D’Souza, A., Aland, G., Kale, N. R., Jadhav, B., Kad, T., Chaturvedi, P., Singh, B., & Khandare, J. J. (2022) · Lab on a Chip · doi:10.1039/d2lc00004k · Cited by 9
Metadata
- Authors
- Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Han, J., & Lim, C. T.
- Affiliations
- Singapore-MIT Alliance for Research and Technology (SG)
- National University of Singapore (SG)
- Corresponding author
- Lim, Chwee Teck
- ORCID
- Venue
- Science Advances
- Published
- 2016-07
- Volume
- 2
- Issue
- 7
- Pages
- e1600274-e1600274
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4956185
- OpenAlex
- W2471117482
- Semantic Scholar
- 4a72640c1b8899f148e8da40a9f771600369426d
- Cited by
- 147
- References
- 52
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 19 · 2022: 21 · 2021: 11 · 2020: 19 · 2019: 22 · 2018: 14 · 2017: 15 · 2016: 4
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Mechanobiology Institute (ID0ETJBI8533)
- Singapore-MIT Alliance for Research and Technology (ID0EXPBI8534)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- liquid biopsy, circulating tumor cells, CTC clusters, drug response monitoring, anticancer drug screening, metastatic breast cancer, microfluidics, drug resistance, precision oncology
- MeSH terms
- Antineoplastic Agents, Biopsy, Breast Neoplasms, Doxorubicin, Female, Humans, Neoplastic Cells, Circulating, Neoplasm Metastasis, Tumor Cells, Cultured, In Situ Hybridization, Fluorescence, Cell Culture Techniques, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.